Showing 1 - 10 results of 10 for search 'Erika Paolini', query time: 0.06s Refine Results
  1. 1
    The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH

    The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH by Erika Paolini, Miriam Longo, Alberto Corsini, Paola Dongiovanni

    Published 2023-01-01
    Get full text
    Article
  2. 2
    Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution

    Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution by Miriam Longo, Erika Paolini, Marica Meroni, Paola Dongiovanni

    Published 2022-03-01
    Get full text
    Article
  3. 3
    Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC

    Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC by Miriam Longo, Erika Paolini, Marica Meroni, Paola Dongiovanni

    Published 2021-04-01
    Get full text
    Article
  4. 4
    Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia

    Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia by Marica Meroni, Miriam Longo, Miriam Longo, Erika Paolini, Erika Paolini, Giada Tria, Michela Ripolone, Laura Napoli, Maurizio Moggio, Anna Ludovica Fracanzani, Anna Ludovica Fracanzani, Paola Dongiovanni

    Published 2022-09-01
    Get full text
    Article
  5. 5
    The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value

    The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value by Erika Paolini, Erika Paolini, Miriam Longo, Miriam Longo, Marica Meroni, Giada Tria, Annalisa Cespiati, Annalisa Cespiati, Rosa Lombardi, Rosa Lombardi, Sara Badiali, Marco Maggioni, Anna Ludovica Fracanzani, Anna Ludovica Fracanzani, Paola Dongiovanni

    Published 2023-03-01
    Get full text
    Article
  6. 6
    α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study

    α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study by Miriam Longo, Erika Paolini, Marica Meroni, Lorena Duca, Irene Motta, Anna Ludovica Fracanzani, Elena Di Pierro, Paola Dongiovanni

    Published 2021-09-01
    Get full text
    Article
  7. 7
    The Alpha-Lipoic Acid Improves Glucose Metabolism and Hyperinsulinemia in Acute Intermittent Porphyria: A Nutritional Concept for the Management of Rare Disorders

    The Alpha-Lipoic Acid Improves Glucose Metabolism and Hyperinsulinemia in Acute Intermittent Porphyria: A Nutritional Concept for the Management of Rare Disorders by Miriam Longo, Erika Paolini, Marica Meroni, Daniel Jericó, Karol M. Córdoba, Michele Battistin, Stefano Gatti, Elena Di Pierro, Antonio Fontanellas, Paola Dongiovanni

    Published 2024-01-01
    Get full text
    Article
  8. 8
    Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

    Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease by Marica Meroni, Miriam Longo, Rosa Lombardi, Erika Paolini, Chiara Macchi, Alberto Corsini, Cesare R. Sirtori, Anna Ludovica Fracanzani, Massimiliano Ruscica, Paola Dongiovanni

    Published 2022-03-01
    Get full text
    Article
  9. 9
    The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients

    The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients by Marica Meroni, Miriam Longo, Erika Paolini, Anna Alisi, Luca Miele, Emilia Rita De Caro, Giuseppina Pisano, Marco Maggioni, Giorgio Soardo, Luca Vittorio Valenti, Anna Ludovica Fracanzani, Paola Dongiovanni

    Published 2021-04-01
    Get full text
    Article
  10. 10
    The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation

    The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation by Nadia Panera, Marica Meroni, Miriam Longo, Annalisa Crudele, Luca Valenti, Emanuele Bellacchio, Luca Miele, Valentina D'Oria, Erika Paolini, Marco Maggioni, Anna Ludovica Fracanzani, Anna Alisi, Paola Dongiovanni

    Published 2021-03-01
    Get full text
    Article

Search Tools: